{
    "title": "104_hr2839",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Medicare Medication Evaluation and \nDispensing System Act of 1995''.\n\nSEC. 2. ESTABLISHMENT OF MEDICATION EVALUATION AND DISPENSING SYSTEM \n              UNDER MEDICARE.\n\n    (a) In General.--Title XVIII of the Social Security Act (42 U.S.C. \n1395 et seq.) is amended by inserting after section 1888 the following \nnew section:\n\n         ``medicare medication evaluation and dispensing system\n\n    ``Sec. 1889. (a) Establishment.--\n            ``(1) In general.--In accordance with the requirements of \n        this section, the Secretary shall establish and operate the \n        Medicare Medication Evaluation and Dispensing System (hereafter \n        in this section referred to as the `MMEDS') to provide for--\n                    ``(A) prospective and retrospective review of \n                prescription drugs furnished to Medicare beneficiaries \n                (in accordance with subsection (b));\n                    ``(B) educating physicians, patients, and \n                pharmacists regarding the appropriate use of \n                prescription drugs (in accordance with subsection (c)); \n                and\n                    ``(C) the establishment of standards for counseling \n                Medicare beneficiaries (consistent with the laws of the \n                State in which a beneficiary resides) regarding the \n                appropriate use of prescription drugs.\n            ``(2) Treatment of drugs not covered under medicare.--The \n        MMEDS shall provide for review, information, and counseling \n        with respect to any prescription drug furnished to a Medicare \n        beneficiary without regard to whether or not payment may be \n        made for the drug under this title.\n            ``(3) Medicare beneficiary defined.--In this section, a \n        `Medicare beneficiary' is any individual entitled to benefits \n        under part A or enrolled under part B.\n    ``(b) Requirements for Review of Prescriptions.--\n            ``(1) In general.--The MMEDS shall provide on-line \n        prospective review of prescriptions on a 24-hour basis and \n        periodic retrospective review of claims.\n            ``(2) Prospective drug utilization review.--\n                    ``(A) In general.--The MMEDS shall provide for on-\n                line prospective review of each outpatient prescription \n                drug prescribed for a Medicare beneficiary before the \n                prescription is filled or the drug is furnished, \n                including screening for potential drug therapy problems \n                due to therapeutic duplication, drug-to-drug \n                interactions, drug-disease contraindications, and \n                incorrect drug dosage or duration of drug treatment.\n                    ``(B) Discussion of appropriate use.--In conducting \n                prospective review under the MMEDS, any individual or \n                entity that dispenses an outpatient prescription drug \n                shall offer (consistent with the law of the State in \n                which the patient resides) to discuss with the patient \n                to whom the drug is furnished or the patient's \n                caregiver (in person if practicable, or through access \n                to a toll-free telephone service) information regarding \n                the appropriate use of the drug, potential interactions \n                between the drug and other drugs dispensed to the \n                individual, and such other matters as the Secretary may \n                require.\n                    ``(C) Additional duties.--In carrying out this \n                paragraph, the Secretary shall--\n                            ``(i) develop public domain software which \n                        could be used by carriers and pharmacies to \n                        provide the on-line prospective review; and\n                            ``(ii) study the feasibility and \n                        desirability of requiring patient diagnosis \n                        codes on prescriptions and the feasibility of \nexpanding the prospective drug utilization review program to include \nthe identification of drug-disease contraindications, interactions with \nover-the-counter drugs, and drug-allergy interactions.\n            ``(3) Retrospective drug utilization review.--As part of \n        the MMEDS, the Secretary shall provide for a retrospective drug \n        utilization review program to provide for the ongoing periodic \n        examination of claims data and other records on outpatient \n        prescription drugs furnished to Medicare beneficiaries in order \n        to identify patterns of inappropriate or medically unnecessary \n        patient care.\n            ``(4) Use of electronic system.--\n                    ``(A) In general.--As part of the MMEDS, the \n                Secretary shall establish, by not later than June 1, \n                1997, a point-of-sale electronic system for use by \n                carriers and pharmacies in the submission of \n                information respecting outpatient prescription drugs \n                dispensed to Medicare beneficiaries. Such system shall \n                be consistent with the standards established by the \n                National Council of Prescription Drug Programs.\n                    ``(B) Technical assistance.--The Secretary shall \n                provide technical assistance in the use of the \n                electronic system established under subparagraph (A) to \n                carriers and pharmacies.\n    ``(c) Education Regarding Appropriate Use of Prescription Drugs.--\n            ``(1) In general.--Under the MMEDS, the Secretary (either \n        directly or through contract) shall provide for an educational \n        outreach program to educate patients, pharmacists, and other \n        health care providers concerning--\n                    ``(A) instances or patterns of unnecessary or \n                inappropriate prescribing or dispensing practices for \n                outpatient prescription drugs,\n                    ``(B) instances or patterns of substandard care \n                with respect to such drugs,\n                    ``(C) potential adverse reactions and interactions, \n                and\n                    ``(D) appropriate use of generic products.\n            ``(2) Information on changes in prescribing and dispensing \n        practices.--Under the program described in paragraph (1), the \n        Secretary shall provide information (in such format as the \n        Secretary considers appropriate) on changes in prescribing and \n        dispensing practices to promote the appropriate use of \n        prescription drugs.\n    ``(d) Privacy Protection.--The Secretary shall establish standards \nto protect from public disclosure any information provided by or \nthrough the MMEDS that identifies an individual and relates to the \nindividual's physical or mental health and the identity of any \nindividual (whether a patient or an individual involved in the \nprescribing, dispensing, or administration of the drug) who is the \nsubject of such information.\n    ``(e) Assistance for Participating Pharmacists.--\n            ``(1) In general.--The Secretary shall provide to each \n        pharmacist meeting the requirements of paragraph (2)--\n                    ``(A) a distinctive emblem (suitable for display to \n                the public) indicating that the pharmacy participates \n                in the MMEDS, and\n                    ``(B) upon request, such technical assistance as \n                the Secretary determines may be necessary for the \n                pharmacist to submit information to and retrieve \n                information from the electronic system established \n                under subsection (b)(4).\n            ``(2) Requirements described.--A pharmacist meets the \n        requirements of this paragraph if the pharmacist is legally \n        authorized under State law (or the State regulatory mechanism \n        provided by State law) of the State in which the drug is \n        received by the beneficiary to dispense outpatient prescription \n        drugs and meets other participation standards established by \n        the Secretary with respect to the following:\n                    ``(A) Maintenance of patient records.\n                    ``(B) Accuracy of information submitted under the \n                MMEDS.\n                    ``(C) Patient counseling.\n                    ``(D) Performance of drug use review activities \n                under the MMEDS.\n    ``(f) Adoption of Medicaid Programs.--To the extent considered \nappropriate by the Secretary, the MMEDS with respect to drugs furnished \nin a State may include elements applicable to the furnishing of covered \noutpatient drugs under the State Medicaid program under section \n1927.''.\n    (b) Recommendations on Coordination With Programs Under Other \nPlans.--Not later than October 1, 1996, the Secretary of Health and \nHuman Services shall submit recommendations to Congress on measures--\n            (1) to ensure the coordination of information collected and \n        disseminated under the Medicare Medication Evaluation and \n        Dispensing System established under section 1889 of the Social \n        Security Act (as added by subsection (a)) with information \n        provided to and collected from similar programs providing \n        services to Medicare beneficiaries enrolled in health care \n        plans (including plans of an organization described in section \n        1833(a)(1)(A) of such Act or an eligible organization with an \n        agreement in effect under section 1876 of such Act, plans \n        serving as primary plans section 1862(b) of such Act, and \n        medicare supplemental policies described in section 1882 of \n        such Act); and\n            (2) to avoid the duplication of services provided under \n        such System with services provided under such similar programs.\n    (c) Special Rules for Carriers.--\n            (1) Use of regional carriers.--Section 1842(b)(2) of the \n        Social Security Act (42 U.S.C. 1395u(b)(2)) is amended by \n        adding at the end the following new subparagraph:\n    ``(E) With respect to activities related to the Medicare Medication \nEvaluation and Dispensing System under section 1889, the Secretary may \nenter into contracts with carriers under this section to perform the \nactivities on a regional basis.''.\n            (2) Additional functions.--Section 1842(b)(3) of such Act \n        (42 U.S.C. 1395u(b)(3)) is amended--\n                    (A) by striking ``and'' at the end of subparagraph \n                (I); and\n                    (B) by inserting after subparagraph (I) the \n                following new subparagraphs:\n            ``(J) if it makes determinations with respect to outpatient \n        prescription drugs which are subject to the Medicare Medication \n        Evaluation and Dispensing System under section 1889, will \n        receive information transmitted under the electronic system \n        established under section 1889(b)(4);\n            ``(K) will enter into such contracts with organizations \n        described in subsection (f)(3) as the Secretary determines may \n        be necessary to implement and operate (and for related \n        functions with respect to) the electronic system established \n        under section 1889(b)(4); and''.\n            (3) Payment on other than a cost basis.--Section \n        1842(c)(1)(A) of such Act (42 U.S.C. 1395u(c)(1)(A)) is \n        amended--\n                    (A) by inserting ``(A)'' after ``(c)(1)'',\n                    (B) in the first sentence, by inserting ``, except \n                as otherwise provided in subparagraph (B),'' after \n                ``under this part, and'', and\n                    (C) by adding at the end the following:\n    ``(B) To the extent that a contract under this section provides for \nactivities related to the Medicare Medication Evaluation and Dispensing \nSystem under section 1889, the Secretary may provide for payment for \nthose activities based on any method of payment determined by the \nSecretary to be appropriate.''.\n            (4) Use of other entities.--Section 1842(f) of such Act (42 \n        U.S.C. 1395u(f)) is amended--\n                    (A) by striking ``and'' at the end of paragraph \n                (1),\n                    (B) by striking the period at the end of paragraph \n                (2) and inserting ``; and'', and\n                    (C) by adding at the end the following:\n            ``(3) with respect to activities related to the Medicare \n        Medication Evaluation and Dispensing System under section 1889, \n        any other private entity which the Secretary determines is \n        qualified to conduct such activities.''.\n\nSEC. 3. RECOMMENDATIONS ON MEDICARE COVERAGE OF PHARMACIST PROFESSIONAL \n              SERVICES.\n\n    Not later than the expiration of the 2-year period which begins on \nthe date of the initial operation of the Medicare Medication Evaluation \nand Dispensing System under section 1889 of the Social Security Act (as \nadded by section 2(a)), the Secretary of Health and Human Services \nshall submit to Congress (in consultation with actively practicing \npharmacists)--\n            (1) an analysis of the effect on net aggregate expenditures \n        under the Medicare program from the establishment and operation \n        of such System; and\n            (2) such recommendations as the Secretary considers \n        appropriate regarding the coverage of and payment for \n        pharmacist professional services under part B of the medicare \n        program as the Secretary considers appropriate, except that the \n        Secretary may recommend coverage of and payment for such \n        services only under a methodology which does not result in an \n        increase in net expenditures under the program (taking into \n        account reductions in expenditures under the program as a \n        result of demonstrable reductions in the inappropriate use of \n        outpatient prescription drugs).\n\nSEC. 4. DISTRIBUTION OF CONSUMER GUIDE TO OUTPATIENT PRESCRIPTION \n              DRUGS.\n\n    Not later than January 1, 1997, the Secretary of Health and Human \nServices shall publish and disseminate a consumer guide to outpatient \nprescription drugs to assist medicare beneficiaries in reducing \nexpenditures for outpatient prescription drugs and to assist \nindividuals and entities furnishing items and services to such \nbeneficiaries in determining the cost-effectiveness of such drugs."
}